Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
70.43B | 68.17B | 72.42B | 80.08B | 77.00B | Gross Profit |
14.39B | 14.23B | 15.51B | 18.69B | 15.59B | EBIT |
-2.23B | -1.62B | -803.34M | 1.31B | -927.92M | EBITDA |
-1.53B | -1.26B | 374.34M | 1.50B | -1.16B | Net Income Common Stockholders |
-2.26B | -1.94B | -829.47M | 625.74M | -2.30B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
2.68B | 4.83B | 877.09M | 5.20B | 7.15B | Total Assets |
18.90B | 19.79B | 16.36B | 26.86B | 26.68B | Total Debt |
5.87B | 5.04B | 5.78B | 10.92B | 11.80B | Net Debt |
3.19B | 215.13M | 4.90B | 5.73B | 4.65B | Total Liabilities |
14.49B | 13.12B | 14.02B | 23.63B | 84.52M | Stockholders Equity |
4.41B | 6.67B | 2.34B | 3.24B | 2.64B |
Cash Flow | Free Cash Flow | |||
-3.06B | -1.41B | -4.12B | 2.71B | 3.42B | Operating Cash Flow |
-1.24B | -1.30B | -4.09B | 2.75B | 4.04B | Investing Cash Flow |
-1.76B | -106.75M | 5.00B | -38.33M | -727.01M | Financing Cash Flow |
860.25M | 5.36B | -5.23B | -994.73M | -977.45M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥10.47B | 7.00 | 2.38% | 15.66% | 2.87% | ||
77 Outperform | ¥9.13B | 9.28 | 4.31% | 2.42% | 154.96% | ||
76 Outperform | ¥11.55B | 11.00 | 1.55% | 6.01% | -21.51% | ||
70 Outperform | ¥10.96B | 6.93 | 1.47% | 0.19% | 32.51% | ||
65 Neutral | $8.88B | 15.05 | 4.75% | 203.76% | 3.54% | -2.50% | |
55 Neutral | ¥12.30B | ― | 2.39% | 0.65% | -679.30% | ||
41 Neutral | ¥10.15B | ― | ― | -5.60% | -23.60% |